| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.4M | -21.0% |
| Cost of Revenue | $24.3M | -8.5% |
| Gross Profit | $26.1M | -29.9% |
| R&D Expense | $13.7M | +16.2% |
| SG&A Expense | $14.1M | -1.1% |
| Operating Income | -$7.1M | -220.5% |
| Pre-tax Income | $741K | -91.8% |
| Income Tax | -$40K | -150.0% |
| Net Income | $781K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.1M | +13.9% |
| Accounts Receivable | $11.7M | +1.5% |
| Inventory | $9.1M | +8.6% |
| Current Assets | $64.2M | +10.9% |
| Total Assets | $77.8M | +15.6% |
| Current Liabilities | $9.9M | +12.9% |
| Long-term Debt | $1.8M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.1M | -45.9% |
| Capital Expenditures | $3.0M | +117.2% |
| Investing Cash Flow | -$3.1M | -120.9% |
| Financing Cash Flow | $1.1M | +169.8% |
| Free Cash Flow | $4.0M | -65.5% |
| -91.4% |
| EPS (Basic) | $0.04 | -90.9% |
| EPS (Diluted) | $0.04 | -90.5% |
| Total Liabilities |
| $15.2M |
| +13.6% |
| Stockholders' Equity | $62.6M | +16.1% |